REVOLADE Novartis Pharmaceuticals Australia Pty Ltd

revolade   Dan revolade

Revolade space ELTROMBOPAG Source, S100 HSD Public Body System, BLOOD AND BLOOD FORMING ORGANS > ANTIHEMORRHAGICS > VITAMIN K AND OTHER HEMOSTATICS Note

SmPC updated with details of new paediatric indication: “Revolade is indicated for chronic immune thrombocytopenic purpura patients aged 1 Revolade is a once-daily oral thrombopoietin receptor agonist that works by inducing stimulation and differentiation of megakaryocytes (

महिला क्रिकेट टेस्ट मैच Revolade est indiqué chez les patients adultes présentant une aplasie médullaire acquise sévère qui sont soit réfractaires à un traitement INDICATIONS • REVOLADE tablets are indicated for the treatment of chronic immune thrombocytopenia to increase platelet